Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines
出版年份 2011 全文链接
标题
Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 61, Issue 1, Pages 109-117
出版商
Springer Nature
发表日期
2011-11-25
DOI
10.1007/s00262-011-1141-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
- (2011) Mary L. Disis CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research
- (2011) J. L. Gulley et al. CLINICAL CANCER RESEARCH
- Prostate Cancer Immunotherapy: Figure 1.
- (2011) Kenneth F. May et al. CLINICAL CANCER RESEARCH
- Impact of tumour volume on the potential efficacy of therapeutic vaccines
- (2011) J. L. Gulley et al. Current Oncology
- Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination
- (2010) Matteo Vergati et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy
- (2010) W. D. Stein et al. CLINICAL CANCER RESEARCH
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Endpoints for Cancer Immunotherapy Trials
- (2010) A. Hoos et al. JNCI-Journal of the National Cancer Institute
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression
- (2010) R. A. Madan et al. ONCOLOGIST
- Chemotherapy and radiotherapy: Cryptic anticancer vaccines
- (2010) Yuting Ma et al. SEMINARS IN IMMUNOLOGY
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design
- (2009) Ravi A Madan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
- (2008) M. A. Morse et al. BLOOD
- Analysis of Overall Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Vaccine, Nilutamide, and Combination Therapy
- (2008) R. A. Madan et al. CLINICAL CANCER RESEARCH
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor Growth Rates Derived from Data for Patients in a Clinical Trial Correlate Strongly with Patient Survival: A Novel Strategy for Evaluation of Clinical Trial Data
- (2008) W. D. Stein et al. ONCOLOGIST
- Allogeneic whole-cell vaccine: a phase I/II study in men with hormone-refractory prostate cancer
- (2004) J.D. Eaton et al. BJU INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started